-
Diabetes Drug Patients Use For Weight Loss May Have Heart Benefits
Known by their brand names like Ozempic and Wegovy, these approved treatments for type 2 diabetes patients have made headlines recently for their effectiveness at treating obesity and helping people with or without diabetes lose weight.
-
These 3 Food Habits Are Linked to Millions of Cases of Type 2 Diabetes, Study Finds
An ambitious global study of Type 2 diabetes has come to a stark conclusion: 70% of all new cases annually can be linked to dietary habits, and three in particular play the biggest role in development of the metabolic disease. The study, published Monday in Nature Medicine, looked at 28 years of data from 184 countries, in an effort to…
-
Novo Nordisk to Slash U.S. Insulin Prices by Up to 75%, Following Move by Eli Lilly
Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
-
What Is Insulin?
Insulin plays an essential role in the human body, especially for the 37.3 million people in the U.S. who have diabetes, according to the National Diabetes Statistics Report.
-
What Is Ozempic Face? Some Using Diabetes Drug for Weight Loss Report This Side Effect
The drug has been around in some form or another for years as a once-weekly non-insulin injection to help adults control their blood sugar but a combination of factors now has vaulted the name Ozempic into the lexicons of people who may not even have diabetes all, especially in recent months. It’s become such a talker, in fact, that...
-
FDA Approves First Drug to Delay Progression of Type 1 Diabetes
The FDA approved the new diabetes treatment Tzield, an injectable treatment that can slow the progression of Type 1 diabetes in patients with stage 2 and delay the need for injectable insulin by two years.